RDC — Redcare Pharmacy NV Cashflow Statement
0.000.00%
- €1.22bn
- €1.36bn
- €2.37bn
- 38
- 44
- 22
- 22
Annual cashflow statement for Redcare Pharmacy NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.866 | -65.7 | -69.2 | -17.3 | -39 |
| Depreciation | |||||
| Non-Cash Items | 4.17 | 22 | 18 | 9.41 | 3.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.57 | 28.3 | -17.4 | 12 | -10.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 17.8 | 11.6 | -29.1 | 61.5 | 22.1 |
| Capital Expenditures | -53.3 | -43.2 | -53.5 | -38.2 | -42.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 13.2 | -41.1 | -84.5 | -21.7 | 50.5 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -40.2 | -84.3 | -138 | -60 | 8.38 |
| Financing Cash Flow Items | -13 | -6.38 | -7.07 | -8.02 | -8.97 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50.2 | 230 | -13.5 | 15 | -17.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 27.8 | 157 | -181 | 17.4 | 12.7 |